(Q36011664)

11 August 2017

1 reference

title

Use of natural killer cells in hematopoetic stem cell transplantation (English)

1 reference

stem cell transplantation

11 August 2017

main subject

1 reference

2

Stern M

1 reference

11 August 2017

Passweg JR

1

1 reference

11 August 2017

Koehl U

series ordinal

3

1 reference

11 August 2017

Uharek L

series ordinal

4

1 reference

11 August 2017

Tichelli A

series ordinal

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Bone Marrow Transplantation

11 August 2017

published in

1 reference

11 August 2017

volume

35

1 reference

11 August 2017

issue

7

1 reference

11 August 2017

page(s)

637-643

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704810

11 August 2017

exact match

0 references

cites work

New aspects of natural-killer-cell surveillance and therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Natural killer cells and viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

What is a natural killer cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Unravelling natural killer cell function: triggering and inhibitory human NK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Alloreactive killer cells: hindrance and help for haematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

The immunobiology of natural killer cells and bone marrow allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Allogeneic transplantation across major HLA barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Transplants across human leukocyte antigen barriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Genetically haploidentical stem cell transplantation for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Innate immunity against hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Cellular therapy: exploiting NK cell alloreactivity in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Determinants of antileukemia effects of allogeneic NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

A clinical role for peripheral blood lymphocyte infusions and perspectives on collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Relevance of KIR gene polymorphisms in bone marrow transplantation outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Purification of human natural killer cells using a clinical-scale immunomagnetic method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Lymphocyte collection for donor leucocyte infusion from normal donors: estimation of the minimum processed blood volume and safety of the procedure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Mobilization of NK cells by exercise: downmodulation of adhesion molecules on NK cells by catecholamines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704810

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704810

1 reference

11 August 2017

1 reference